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Abstract
The suitability of V4 vaccine coated on cracked local grain (maize) and its husks and used for oral vaccination of 
chickens was assessed. Seventy-two (72) birds aged three (3) weeks and above were divided into six groups of twelve 
(12) birds per group. The birds were bled to determine their prevaccination HI antibody status while five different 
samples of cracked maize were coated with the V4 vaccine and fed to the chickens orally in each of the groups. All birds 
in the group including the controls were bled at 7, 14 and 21 days post vaccination to determine the presence and 
level of antibody response in each of the groups. Results obtained showed that prevaccination haemagglutination 
inhibition (HI) titre was less than two (log2) in 18% of the birds used in this experiment, however 14% of the birds had 
an HI titre of ≤ 4. The post vaccination antibody titre showed that birds vaccinated with vaccine coated maize gave a 
post vaccination HI antibody titre of between Log2(6-8). when the coated maize samples were soaked in water at room 
temperature and assessed after 24 hours, the treated maize parts gave >6.3 log10 EID50 and above while the untreated 
parts gave < 3.0 log10 EID50. The experiment showed that whole maize and husks, which were not treated, may contain 
agents which are virus inhibitory. Form this research the treated maize which was soaked and washed gave a higher 
geometric mean titre, hence tends to be good carriers of the virus (vaccine). It is therefore concluded from this work 
that processed cracked maize could be a good carrier of NDV4 vaccine. It is hereby recommended that only treated 
maize could be used as carrier for the V4 vaccine.
Background
The Newcastle disease virus (NDV) is classified within
the genus Paramyxovirus of the family Paramyxoviridae
[1]. The virus has a single stranded RNA like other mem-
bers of the Paramyxovirididae family. The Newcastle dis-
ease virus possesses two surface proteins that are
important in the identification and biological characteris-
tics of the virus [2].
The disease is primarily a viral disease of chickens in
particular and other avian species [3,4]. Human infec-
tions has however been reported among laboratory work-
ers and other poultry workers. The disease is
characterized by conjunctivitis, without cornea involve-
ment in man, [5].
Newcastle disease is worldwide in distribution [6]. Nev-
ertheless international recording and reporting of New-
castle disease has been carried out by the Food and
Agricultural Organization of the United Nations and OIE
which form the basis of several assessment of the
geographica1 distribution of the disease [6].
The disease has no treatment (i.e. cure) but is however
controlled by vaccination using the imported and the
three vaccines currently produced at the Virology Divi-
sion of the National Veterinary Research Institute Vom. It
has been established that the Newcastle disease vaccine
prevents possible outbreak of the virus [7]. Chickens can
be immunized against New castle disease, while low viru-
lence live-virus vaccines are administered by a variety of
routes such as drinking water, intra-ocular, intra nasal or
by sprays while killed oil emulsion vaccines are adminis-
tered to pullets intramuscularly or subcutaneously as
'final vaccine prior to the onset of egg production, [8].
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nate chicken red blood cells in vitro (and some times red
blood cells from other animal species). This biological
activity is known as haemagglutination (HA) and is the
basis of the common tests to detect haemagglutination
viruses in the family. Haemagglutination inhibition (HI)
test is used to detect antibodies to this virus, though
other serological tests are available, [9,10].
Transmission of the virus is most common through
bird to bird and humans or formites usually via droplets
from the respiratory tract or through faeces. The virus is
shed from infected birds in all secretions and excretions.
In dry conditions aerosol borne infected particles pro-
mote the spread. Infection is acquired by birds through
inhalation of infected droplets or particles or through
ingestion of infected food, [11].
In this study therefore, efforts were made to determine
the suitability of maize coated with V4 virus as a carrier in
the vaccination of chickens against Newcastle disease.
Materials and methods
Samples collection
One hundred and twenty (120) day old cockerels were
used for this research. These birds were obtained and
brooded for three weeks, until the maternal antibodies
were not detectable according to the method of Allan and
Gough [12]. The chickens were fed with chick mash for
eight [8] weeks, which were later changed to growers
mash at the 9th week. They were maintained on this feed
throughout the period of the experiment also the chick-
ens were given portable water twice daily with good poul-
try management practices, according to the method of
Darminto, [13]. Blood samples were collected from the
birds at 7 days interval for 21 days. The blood samples
were allowed to clot at room temperature, stored at +4°C
and centrifuged at 3000 rpm for 5 minutes in a refriger-
ated centrifuge. The sera collected were then stored at -
20°C until ready for use.
Processing of the grains
Ten measures of maize grain were cracked to small sizes,
to ease swallowing by the birds. This was then divided
into five equal groups which were fed to the birds in five
different cages:
The first group involves the maize husk measuring 72 g
this was soaked in water for three days, with daily
changes of water throughout the period, after which it
was sun-dried, this is to be used for the birds in cage 1.
The second group was also made up of maize husks
measuring 72 g which were left unsoaked in water; this is
to be used for the birds in cage 2.
The third group was made up of the cracked maize
(with removed husks), which was soaked in water for
three days, with a daily change of water (1:3; w/v). After
the third day, it was sun-dried on a clean and well washed
surface this was for the birds in cage 3.
The fourth group included part of the cracked portion
above. This was left unsoaked and used for the birds in
cage 4. These procedures were according to the method
described by Alders, and Spradbrow, [9,10].
The fifth group was made up of maize offal which was
obtained by soaking the entire maize grain in water for
four days after which it was ground and sieved. The
sieved out part (offal) was then sun dried. This was used
for the birds in cage 5. This method was adopted by,
[9,10].
Vaccine administration
One ampoule of already freeze dried NDV4 vaccine was
reconstituted in 5 mls of clean sterile non-chlorinated
water. The 5 mls vaccine suspension was further diluted
in 50 mls of clean non-chlorinated water and maintained
in ice trough, ready for use, According to the method
described in the OIE Manual [14].
Preparation and coating of carrier maize grain with the 
virus
Forty-eight grams(48 g) of each of these maize carriers
were mixed thoroughly and separately with 10 mls of the
NDV4 vaccine suspension to ensure that the vaccine virus
adhered well to the carriers, (this was aseptically done
manually, using sterile equipments and hand gloves,
while the environment was thoroughly disinfected). They
were kept at +4°C ready for use.
Method of vaccination
The first vaccination of birds was carried out on the 9th
week of age; the various groups of birds were vaccinated
using the different vaccine carriers. All the birds were
starved overnight of feed and water. The vaccines carriers
were given as follows:
Group A
The birds in group A were fed with the unsoaked maize
husk mixed with the V4 vaccine.
Group B
The in birds group B were given the soaked maize husk
carrying the V4 vaccine.
Group C
The birds in group C were fed with the soaked cracked
maize mixed with the V4 vaccine.
Group D
The birds groups D were fed with the unsoaked cracked
maize combined with the V4 vaccine.
Group E
The birds in group E were vaccinated using the maize
offal mixed with the V4 vaccine.
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The group F birds were kept as control birds without any
vaccination (fed with carrier without vaccine coating).
All the birds and the controls were adequately provided
with portable water and maintenance feed.
Booster vaccination
The second vaccination (booster dose) was carried out
after 21 days from the first vaccination at the twelfth
(12th) week of age. This was done using the same vaccine
carriers, quantities and procedures as it was done in the
first vaccination in all the groups.
Post vaccination blood sample collection
1 ml each of blood samples were collected from all the
experimental birds at day 7, 14 and 21. The bleeding pro-
cess was carried out aseptically as described earlier and
the blood was put into sterile and dry vials and allowed to
clot overnight. These were then centrifuged at 3000 rpm
for 5 minutes in a refrigerated centrifuge. The 3 sera sam-
ples collected per bird were then stored at -20°C until
ready for use, according to the method of Alders and
Spradbrow [9].
Haemagglutination test
The presence and titer of the haemaggluting virus were
tested using the method of Allan and Gough (1976). A U-
bottomed shaped microtitre Perspex plate was used for
the virus titration. The antigen (1: 1 0 dilution) was pre-
pared in phosphate buffer saline (PBS, PH 7.2). One row of
ten wells were marked A1-10 was used for each antigen to
be tested. Two other wells A11 and A12 were used for cell
and antigen control.
Haemagglutination inhibition test
The haemagglutination Inhibition (HI) test, was based on
the inhibition of viral agglutination by the specific serum
antibody, according to the method of Allan and Gough,
[15]. A twofold serial dilution in PBS of the Birds (spe-
cific) serum was made from the first well to the eleventh
well (i.e.) wells 1 - 11. After which 0.025 ml of the virus
dilutions containing 4HAU was added to each of the
serum dilution. It was uniformly mixed and incubated at
room temperature for 45 minutes; this is to enable the
virus - serum mixture to react. After this 0.025 ml of 1%
suspension of the chicken red blood cell was added to
each of the mixtures in the wells and allowed to settle for
60 minutes at + 4°C, while the 12th well contains only PBS
and the 1% suspension of the chicken red blood cell. The
serum titre were then read, as the highest dilution of
serum inhibiting haemagglutination by the virus, which is
expressed as the reciprocal of that serum dilution, while
the control well shows a clear and visible button of the
red cells.
Eid50 determination
One gram of each V4 virus coated maize grain samples,
were kept into a sterile McCartney bottle and 10.0 ml of
PBS containing antibiotics, was ascetically added, shaken
and allowed to stand for 24 hours. The mixture was then
spun at 3000 rpm for 30 minutes at 4°C in a refrigerated
centrifuge. The supernatant were collected and diluted
serially in tenfold from 10-2-10-10. Beginning from the
highest dilution, 0.1 ml of each dilution was inoculated
into 5 - 10 days old embryonated egg already prepared for
inoculation. The inoculated eggs were then sealed with
molten candle wax and incubated for 3 days at 37°C along
with the control eggs containing no inoculums. At the
end of incubation the eggs were recandled to remove the
dead eggs, while the viable ones were chilled in the cold
room at 4°C overnight. After chilling, haemagglutination
spot test was performed on each egg to determine the
presence of virus, by mixing a drop of the allantoic fluid
with a drop of 10% washed chicken. Red blood cells on a
clean white tile mixed and rocked.
Those that showed haemagglutination reaction were
considered positive (+) for each dilution and the E1D50
was calculated using the Reed and Muench method, [16].
Results
Haemagglutination inhibition (HI) titration results
The result obtained from the screened birds showed a
mean prevaccination haemagglutination inhibition titre
(HI) titer of < 2 which implies that the birds had no
detectable antibody to the virus. Details as presented in
table 1. When the birds were later vaccinated, the results
of HI post vaccination at 7, 14 and 21 days showed a
higher HI titer. The results obtained from soaked cracked
maize grain, maize offal, and soaked husk of the maize
grain samples respectively showed a rise in antibody titer
when fed to the birds, as seen on table 2. The result
obtained from unsoaked samples of the cracked maize
grain and husks respectively observed a drop in titer to
the vaccine for birds in that group. The highest HI titer
result was obtained from soaked cracked maize carrier
followed by soaked maize husk. The maize offal was used
as a control, because it is known to have been processed
through water and has been reported to have no virucidal
effect on the Newcastle disease virus [7]. While the result
obtained from the maize offal is as shown in Table 3.
Statistical analysis
Using two factor analysis of variance, the birds showed
significant mean antibody geometric titer (P > 0.05) dur-
ing the post vaccination period using the differently pro-
cessed maize grain sample. There seem to be a steady rise
in the antibody titre as the number of days of repeat vac-
cination increases. Applying the Multiple Range Test
(MRT), it was observed that the various parts of grain
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birds and by implication an enhancement of antibody
generation.
Discussion
The ability of maize as a carrier food to deliver viable vac-
cine virus in order to stimulate the production of protec-
tive antibody amongst chickens was the main focus of
this work. The V4 (vaccine), a thermostable strain of NDV
has been used in the control of Newcastle disease in both
exotic and local chicken [1-3]. However this study was
carried out to identify a suitable maize carrier for ease of
vaccinating local and free range chickens.
In this work different processed maize grain compo-
nents mixed (coated) with V4 vaccine suspension was
used to vaccinate chickens experimentally, the result
obtained showed that the cracked maize that were soaked
gave an appreciable high titre compared to those parts
that were Unsoaked. This has been attributed to the
removal of the effects of some inactivating substances on
the grains(such as acids, lectins and other inhibitory sub-
stances) by soaking in water for 3 days. This is similar to
the work of Olabode [7], who used Offal as carrier for the
V4 Vaccine in Nigeria.
According to Agbor [17] some grains (e.g. maize, rice
and, guineacorn) were all found to contain substances
inherent in them capable of inactivating the V4 thermo-
stable Newcastle Disease Virus when coated on them.
This was evidenced with the reduced concentration of
the virus in the unsoaked maize when inoculated into
embryonating eggs giving a 4.3 log10 EID50.
Low titer obtained when the unsoaked maize samples
were used as carrier for the V4 vaccine, showed that
unsoaked grains could not have been a successful delivery
vehicle for the V4 Vaccine compared with the soaked
samples which gave a 6.3 logs EID50.
According to Rehmani and Spradbrow [18]; McMillan
et al., [19] it was observed that the condition for success-
ful use of any chosen food as vaccine carrier is the ability
of such food to allow firm binding or adherence of the
coated vaccine virus without interfering with the virus
viability. According to Echeonwu et al. [20] who used
Cassava granules as a carrier for the (NDV) strain V4
UPM on free range chickens, it was also reported that
lectins play important roles in such virus binding or
adherence to food grain surface, hence the need for soak-
ing such grains in water.
The V4 Vaccine coated on the soaked grains were seen
to be viable for up to 24 hours at room temperature, with
only a minimal loss in titre. Although the V4 vaccine is
thermostable, the vaccine must be used as soon as possi-
ble and with out exposure to direct sunlight.
Conclusion
This method of vaccination will go a long way to reduce
Newcastle Disease related mortalities, thereby improving
confidence in village chicken farmers hence contributing
to poverty alleviation in the rural areas, more so the
method does not require direct contact with the birds
Table 1: Prevaccination HI test result
Group Number of Birds Detectable Antibody
Titer(Log2)
A 12 <2
B 12 <2
C 12 <2
D 12 <2
E 12 <2
F 12 <2
6 72 <2
Table 2: HI titres of post vaccination for the birds screened.
Sampling periods HI titer level (Log2)
(Days) A B C D
7 2 7 7 6
14 2 7 8 7
21 4 9 7 7
KEY:
A - Titer obtained from birds fed with unsoaked cracked maize coated with the V4 Vaccine.
B - Titer obtained from birds fed with soaked cracked maize coated with the V4 Vaccine.
C - Titer obtained from birds Fed with soaked husk mixed with the V4 Vaccine.
D - Titer obtained from birds Fed with the Unsoaked maize husk mixed with the V4 Vaccine.
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with handling birds for individual vaccination coupled
with ease of application by poultry farmers; vaccine deliv-
ery through this medium to chickens of all ages has been
able to give a good result, hence might prove better than
other conventional methods.
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Table 3: HI means titre of post vaccination for birds fed with maize Offal mixed with the V4 Vaccine.
Sampling periods
(Days)
N0. of birds Post Vaccination
HI titer
7 12 7
14 12 7
21 12 9
